Search | Page 31 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Medical Resources

    ... education & awareness about using umbilical cord blood stem cells as a treatment for disease. Salute To Life ... (NMDP) helps people who need a life-saving marrow or blood cell transplant. Dictionaries and Encyclopedias ...

    Page last updated 08/20/2015 - 8:34am.

  2. Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

    ... side effects and best dose of selinexor when given after stem cell transplant in treating patients with acute myeloid leukemia that is at ...

    Clinical Trial last updated 04/29/2016 - 10:38am.

  3. "Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution

    ... sibling donor or are too old for hematopoietic stem cell transplant . Approximately two thirds of patients successfully respond ...

    Research Review last updated 05/02/2016 - 9:13am.

  4. Heather Putney’s Trials (and Travels) with Aplastic Anemia

    ... It has been poisoned by medicine designed to kill every last stem cell. It has been deprived of sleep and nourishment. It has been injected with ...

    Patient Chronicle last updated 08/15/2016 - 8:42am.

  5. Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

    ... use short-duration tacrolimus after a peripheral blood stem cell transplant in certain malignancies that are considered difficult to ...

    Clinical Trial last updated 05/03/2016 - 11:45am.

  6. Randomized Allogeneic Azacitidine Study

    ... with AML, CMML, or MDS after an allogeneic (donor) stem cell transplant . The safety of this drug will also be studied. ...

    Clinical Trial last updated 05/03/2016 - 11:08am.

  7. A Phase II Study of 5-Azacitidine and Sargramostim as Maintenance Treatment After Definitive Therapy for Poor-risk AML or MDS

    ... are in remission after definitive treatment with either stem cell transplant or cytarabine-based consolidation chemotherapy . ...

    Clinical Trial last updated 05/03/2016 - 10:38am.

  8. Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

    ... of two novel conditioning therapies for hematopoietic stem cell transplant (HSCT). The primary focus of both the investigators' ...

    Clinical Trial last updated 05/03/2016 - 10:36am.

  9. Telomere Length and Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia

    ... Telomere length in hematopoietic stem cell transplantation for severe aplastic anemia: is it ready for "prime time"? ...

    Research Review last updated 05/02/2016 - 9:13am.

  10. Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

    ... of an unacceptable toxicity, or hematopoietic stem cell transplant (HSCT). ...

    Clinical Trial last updated 04/28/2016 - 4:16pm.